About 100 Mg Arsenic Trioxide Injection
The 100 mg Arsenic Trioxide Injection is a top-ranking cytotoxic antineoplastic solution, renowned for its flawless compliance with USP standards. Offered in a single-use glass vial, this cost-effective product ensures the lowest price for hospital use in India. Intravenous infusion is the only administration route, and purchase requires a valid prescription. Fully soluble in water and compatible with 0.9% sodium chloride, it is meticulously marketed by trusted brands. Disposal must follow biomedical guidelines, ensuring safety. Regulatory-approved, it's ideal for treating acute promyelocytic leukemia with a shelf life of 24 months.
Competitive Advantages & Applications
100 mg Arsenic Trioxide Injection is used to treat acute promyelocytic leukemia (APL) due to its high efficacy. Its competitive advantages include flawless solubility, ready-to-use presentation, and strict adherence to USP safety standards. It's trusted in hospitals and oncology centers nationwide for intravenous application, combining renowned quality with effective cytotoxic action. The clear, colorless solution makes handling seamless, positioning this injection among the most preferred choices for APL treatment in India.
Sample Availability, Market Reach & Delivery
Samples of 100 mg Arsenic Trioxide Injection are available for medical professionals to assess hospital compatibility. The main domestic market covers India, with punctual delivery timeframes maintained by reliable suppliers. Packing & dispatch are efficiently organized, ensuring every vial is securely sealed. Quotations are promptly provided, and drop-off services adapt to facility needs, establishing dependable support for distributors, exporters, and traders looking to stock this essential cytotoxic antineoplastic agent.
FAQ's of 100 Mg Arsenic Trioxide Injection:
Q: How is 100 mg Arsenic Trioxide Injection administered for patients with APL?
A: 100 mg Arsenic Trioxide Injection is administered exclusively via intravenous infusion in hospital settings, ensuring precise dosing and optimal therapeutic outcomes for acute promyelocytic leukemia (APL).
Q: What precautions must be taken when handling the injection?
A: Due to its cytotoxic nature, the injection should be handled with care by trained hospital staff following strict safety protocols. Proper disposal according to biomedical waste guidelines is essential.
Q: Where can this injection be purchased and who is eligible to buy it?
A: This medication is available from licensed distributors, exporters, and suppliers across India. Purchase requires a valid prescription and is restricted to hospitals and approved medical facilities.
Q: When should the injection be used for patient treatment?
A: It is indicated for use in the treatment of acute promyelocytic leukemia (APL) under hospital supervision, as determined by a medical specialist's prescription and assessment.
Q: What competitive benefits does this product offer for hospitals?
A: The product provides cost-effective, ready-to-use presentation, compatibility with 0.9% sodium chloride, compliance with USP standards, and a long shelf life, making it efficient and convenient for hospital use.
Q: How long is the shelf life and what are the storage requirements?
A: The shelf life is 24 months when stored below 25C and protected from direct light, maintaining the sterility and stability of the injection.